A recent clinical trial found that people living with cardiovascular disease had a major reduction in heart attacks, stroke and other cardiovascular disease events after taking semaglutide continuously for four years
So it works in all individuals, but someone who's not living with obesity doesn't need it
They may be able to appeal to the insurance company or help you find a safe and affordable alternative
I always read the paper, look at the methodology, and understand whats actually going on before commenting
Clinical trials have shown that these medications reduce the risk of major cardiovascular events, including heart attack and stroke
However, Retatrutide remains investigational, and the safety profile is still developing